About Ahlcon Parenterals
Ahlcon Parenterals is a Healthcare company based in Delhi (India) founded in 1992, and was acquired by B Braun in March 2012. Large and small volume parenteral formulations are manufactured for markets. The company has 476 employees. Its chief executive, as recorded, is Indranil Mukherjee. Its Indian entity Ahlcon Parenterals (India) Limited reported revenue of βΉ230 Cr. Its focus areas include Traditional Pharmaceuticals, Generics and Injectables.
Company details
Ahlcon Parenterals was founded in 1992 in Delhi, India, within the pharmaceutical sector. Large and small volume parenteral formulations are produced for domestic and export markets. Operations follow Current Good Manufacturing Practices using advanced processes. Products such as infusion therapy solutions, inhalation nebules, topical drops, and injectables are provided. Compliance with global ISO standards is ensured, alongside sustainable manufacturing approaches.
- Headquarters Delhi, India
- Employees 476
- Stage Acquired
- SectorsHealthcare
- Website ahlconindia.com
- Social LinkedIn
- Acquired by B Braun (Mar 2012)
- Legal Name Ahlcon Parenterals (India) Limited
- Date of Incorporation 20 Jan, 1992
- Jurisdiction New Delhi, Delhi, India
Associated legal entities of Ahlcon Parenterals
Ahlcon Parenterals operates through Ahlcon Parenterals (India) Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ahlcon Parenterals (India) Limited CIN U24239DL1992PLC047245 | Active | 20 Jan 1992 | New Delhi, Delhi | ₹230 Cr | 476 | 8 | View details |
Investors in Ahlcon Parenterals
Ahlcon Parenterals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include B. Braun.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
B. Braun is recognized as a leading medical technology company. | 1839 | bbraun.com | Melsungen, Germany |
Investor details for Ahlcon Parenterals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Ahlcon Parenterals (India) Limited (Ahlcon Parenterals)
Ahlcon Parenterals (India) Limited is the primary company behind Ahlcon Parenterals. The board of Ahlcon Parenterals (India) Limited currently have 6 directors; the longest-serving is Aditya Kumar Banerjee, appointed in 2022. 26 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Aditya Kumar Banerjee DIN 00026862 | Managing Director | 01 Oct 2022 | 4 yrs | Ahlcon Parenterals (India) Limited |
| Eva Fatima Maegerlein DIN 09778123 | Director | 31 Oct 2022 | 3 yrs 11 mo | Ahlcon Parenterals (India) Limited |
| Navin Hans DIN 10103600 | Whole-time director | 28 Apr 2023 | 3 yrs 5 mo | Ahlcon Parenterals (India) Limited |
| Rajesh Garg DIN 00102403 | CFO | 12 Aug 2024 | 2 yrs 2 mo | Ahlcon Parenterals (India) Limited |
| Rajiv Mathur DIN 06931798 | Director | 02 Jul 2025 | 1 yr 3 mo | Ahlcon Parenterals (India) Limited |
| Vinod Kumar Bajaj DIN 00319335 | Director | 02 Jul 2025 | 1 yr 3 mo | Ahlcon Parenterals (India) Limited |
People of Ahlcon Parenterals
1 people are tracked at Ahlcon Parenterals (1 in leadership); the tracked headcount is 476.
| Name | Role | Group |
|---|---|---|
| CEO & MD | Leadership |
Complete people profiles for Ahlcon Parenterals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Ahlcon Parenterals
Figures of Ahlcon Parenterals (India) Limited, the primary company behind Ahlcon Parenterals, for FY 2025. Revenue was ₹230 Cr (0% year on year). Net loss was -₹8.21 Cr (-4% margin). EBITDA was ₹42.77 Cr (19% margin). Revenue has grown at a compounded annual rate of +8% over three years and +5% over five years.
- ₹230 CrRevenue · FY 2025 · 0% YoY
- -₹8.21 CrNet loss · -4% margin
- ₹42.77 CrEBITDA · 19% margin
- ₹192 CrPaid-up capital
- 476Employees (provident fund records)
- +8%Revenue CAGR, 3 years
- +5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ahlcon Parenterals (India) Limited are on its company page.
Detailed financial statements for Ahlcon Parenterals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Ahlcon Parenterals
2 dated milestones of Ahlcon Parenterals across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Ahlcon Parenterals is founded.
- Exit Acquired by B Braun.
Web traffic of Ahlcon Parenterals
The website of Ahlcon Parenterals (ahlconindia.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▲ 23.7% vs previous month
Websites whose visitors overlap most with Ahlcon Parenterals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| apmindustries.co.in | 100% | 2K | #8,058,508 | View details | |
| styleinstones.com | 96% | View details | |||
| paraflex.co.in | 94% | #7,230,723 | View details | ||
kkmetals.com | kkmetals.com | 91% | #9,665,150 | β | |
electricalrubbermat.com | electricalrubbermat.com | 91% | β | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 7 similar websites and full traffic analytics for Ahlcon Parenterals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Ahlcon Parenterals (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | USD 508.93 M | 5,180 | ||
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | USD 6.21 B | 25,870 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ahlcon Parenterals
Ahlcon Parenterals was founded in 1992.
Ahlcon Parenterals is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Indranil Mukherjee is the CEO of Ahlcon Parenterals, as recorded in our data.
Ahlcon Parenterals has 476 employees.
The primary company behind Ahlcon Parenterals, Ahlcon Parenterals (India) Limited, reported revenue of βΉ230 Cr for FY 2025, down 0% year on year.
Ahlcon Parenterals was founded in 1992 in Delhi, India, within the pharmaceutical sector. Large and small volume parenteral formulations are produced for domestic and export markets. Operations follow Current Good Manufacturing Practices using advanced processes. Products such as infusion therapy solutions, inhalation nebules, topical drops, and injectables are provided. Compliance with global ISO standards is ensured, alongside sustainable manufacturing approaches.
Ahlcon Parenterals has 1 investor. Key investors include B. Braun.
Ahlcon Parenterals operates through Ahlcon Parenterals (India) Limited.
Yes. Ahlcon Parenterals was acquired by B Braun in March 2012.
The legal entities of Ahlcon Parenterals currently have 8 directors, including Rajiv Mathur, Eva Fatima Maegerlein, Navin Hans and others.
